In this review we examine the potential of embryonic stem cells (ESCs) for use in the treatment of retinal diseases involving photoreceptors and retinal pigment epithelium (RPE). We outline the ontogenesis of target retinal cell types (RPE, rods and cones) and discuss how an understanding of developmental processes can inform our manipulation of ESCs in vitro. Due to their potential for cellular therapy, special emphasis is placed upon the derivation and culture of human embryonic stem cells (HESCs) and their differentiation towards a retinal phenotype. In terms of achieving this goal, we suggest that much of the success to date reflects permissive in vitro environments provided by established protocols for HESC derivation, propagation and neural differentiation. In addition, we summarise key factors that may be important for enhancing efficiency of retinal cell-type derivation from HESCs. The retina is an amenable component of the central nervous system (CNS) and as such, diseases of this structure provide a realistic target for the application of HESC-derived cellular therapy to the CNS. In order to further this goal, the second component of our review focuses on the cellular and molecular cues within retinal environments that may influence the survival and behaviour of transplanted cells. Our analysis considers both the potential barriers to transplant integration in the retina itself together with the remodelling in host visual centres that is known to accompany retinal dystrophy.
Introduction
The field of embryonic stem cell (ESC) research holds significant potential for the treatment of CNS disorders. The retina is the photosensitive component of the CNS located in the eye. The accessibility of the retina, together with imaging technologies and an extensive knowledge base surrounding the organisation and function of this structure make it a prime candidate for developing cellular therapies for CNS disorders. This point has been highlighted recently by the use of the retina to study development of neural progenitor cells.
Amongst patients that may benefit directly from an ESC-based retinal cellular replacement strategy are those suffering from currently incurable eye diseases such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). In particular, AMD is the leading cause of blindness in the developed world, with approximately 25 to 30 million people affected worldwide by some form of the disease. Within the UK, the percentage of those afflicted by this condition is close to 1% of the population (figures from the Royal National Institute for Blind People and The Macular Disease Society).
The loss of vision in AMD and RP results from death or irreversible damage to the retinal pigment epithelium (RPE) and/or photoreceptors (Curcio et al., 1996; Delyfer et al., 2004; Young, 1987) . However, because the ganglion cell output neurons of the retina are largely preserved (Medeiros and Curcio, 2001; Stone et al., 1992) , this makes the replacement of photoreceptors and RPE a viable option for restoring visual function in such diseases.
The feasibility of RPE cell replacement in AMD has already been demonstrated by autologous transplantation of full thickness RPE/choroid from periphery to macular (MacLaren et al., 2007; van Meurs and Van Den Biesen, 2003) . However, due to the volume of patients with retinal disease, surgical complexity and genetic defects in autologously derived cells, the current review focuses on human embryonic stem cells (HESCs) as a source of material for retinal repair.
A growing body of convergent data indicates that HESCs can give rise to retinal cells following variable degrees of manipulation. In order to more fully understand the mechanisms involved in this process, we examine the developmental cues that specify identity and maintenance of RPE/photoreceptors. We review existing methods for ocular cell derivation from HESCs and highlight how insights gained from the developmental literature are already enhancing the efficiency by which photoreceptor progenitors can be produced.
We argue that the success to date in deriving ocular cell types from HESCs may be at least in part due to the established protocols for derivation, propagation and neural differentiation of these cells. Finally, we address key issues surrounding the introduction of HESC-derived RPE and photoreceptors into a diseased retinal environment. In particular, we highlight the challenges of immune rejection, barriers to cellular integration and neuronal plasticity, which should be considered by future investigations in the field.
Developmental cues for specification of ocular tissue
After an overview of ocular development we focus on molecular cues relevant to the derivation of photoreceptor progenitors (specifically cones) and RPE cells. For more detailed reviews of retinal development and cell-type specification please see reviews by Cepko, Harada and Klassen (Cepko et al., 1996; Harada et al., 2007; Klassen et al., 2004a) .
Overview of ocular development
In vertebrates, neural tissue is defined during the gastrula stage, a process thought to involve antagonism of bone morphogenetic protein (BMP) and Wnt signalling pathways (Glinka et al., 1998; Munoz-Sanjuan and Brivanlou, 2002) . With regard to the present review, two of these molecules are of particular note, the BMP antagonist noggin and the Wnt antagonist Dickkopf-1 (Dkk1).
The antagonism of Wnt signalling during forebrain development helps to define telencephalon and eyefields, with specification of the latter structures involving a hierarchical network of eye field transcription factors (EFTFs) that may be directed by Otx2 and Rx (Stigloher et al., 2006; Zuber et al., 2003) . Other components to consider here are the insulin-like growth factor (IGF) signalling pathway, which is implicated in eye field induction and Notch signalling which has been shown to induce EFTF expression and ectopic eye tissue formation (Onuma et al., 2002) .
Following eye field specification, optic vesicles arise bilaterally from the forebrain and expand into mesodermal tissue of the head. Inductive interactions ensue between the optic vesicles and a thickened portion of overlying surface ectoderm called the lens placode. These interactions lead to invagination of optic vesicles and the formation of optic cup and lens vesicle (Pei and Rhodin, 1970) .
Once formed, the neuroectodermal tissue of the optic cup gives rise to several spatially demarcated structures: neural retina, RPE and, at its far periphery, the epithelium of the iris and ciliary body (Beebe, 1986) . The RPE develops adjacent to the choroid, a structure composed of cells derived from both cranial neural crest and mesenchyme (Etchevers et al., 2001; Noden, 1982; Torczynski, 1982) .
During human eye development, pigmentation is first observed in the external layer of the optic cup (the newly differentiating RPE cells) some time between post-ovulatory weeks 5 and 6 (O'Rahilly, 1966, 1975) . To date, most of our understanding about mammalian RPE development comes from studies in rodents. It is evident from these studies that RPE cells achieve near maximal pigmentation levels early in the developmental process and that they undergo two clear phases of mitosis (Stroeva and Mitashov, 1983) . Interestingly, the second phase of mitosis lacks cytokinesis, a phenomenon resulting in the majority of adult rat RPE cells being binucleated. This is a much neglected and highly conserved feature of vertebrate RPE development with multinucleated cells also commonly observed in human RPE (Han et al., 2006; Stroeva and Mitashov, 1983) .
The neural retina and retinal pigment epithelium
The key cellular decision to be made within the developing optic cup is that of commitment to neuroretinal versus RPE cell fate. In large part, this choice is determined by proximity of neuroepithelial optic cup cells to signals emanating from surrounding extraocular tissues (Fuhrmann et al., 2000; Moshiri et al., 2004) . The proximal optic vesicle is exposed to factors from the surrounding head mesenchyme that convert cells in this location into RPE, while cells positioned towards the distal aspect become neural retina in response to signals from surface ectoderm.
The RPE-genesis signal is thought to derive from TGFb superfamily signalling molecules such as BMP and/or activin (Moshiri et al., 2004) . In this respect, the extraocular mesenchyme has been identified as the key source of RPE-genesis signal in developing chick eyes (Fuhrmann et al., 2000) . In this study, Fuhrmann and colleagues clearly demonstrated that activin A could successfully sub-stitute for extraocular mesenchyme in producing RPE cells and maintaining RPE-specific gene expression. However, BMP signalling may also be of some importance to proper RPE cell development, as over-expression of Noggin results in a regionally specific loss of RPE integrity (Adler and Belecky-Adams, 2002) .
Neural retinal progenitor cells can be generated either directly from neuroepithelium of the developing optic cup, or via the transdifferentiation of RPE cells in the developing avian and amphibian retinae. In both instances, members of the fibroblast growth factor (FGF) family of molecules have been demonstrated to be of clear importance (Araki, 2007; Moshiri et al., 2004) . For instance, basic FGF (bFGF) initiates the transition from neuroepithelium towards neuroretinal phenotype in chick (Pittack et al., 1997 (Pittack et al., , 1991 and expression of FGF9 in embryonic mouse RPE results in conversion of these cells into neural retina . Within the developing ocular environment, FGF molecules are released from surface ectoderm/lens placode during optic vesicle invagination. The lens itself has a conserved role in retinal development (Yamamoto and Jeffery, 2000) which may involve production of short-range inducing signals (Thut et al., 2001) .
The Wnt signalling pathway is also important for proliferation of undifferentiated retinal progenitors (Kubo et al., 2003) , with Wnt2b (also known as Wnt13) generating laminar organisation in developing chick retina . In mammals this organising role is performed, at least in part by the RPE cells (Raymond and Jackson, 1995) .
The conventional distinction outlined above between RPE and non-pigmented neural retina is not based on embryonic origin per se but largely on the pigmented appearance of RPE versus other retinal cells. A similar distinction is not made between pigmented nigral neurons of the primate midbrain and other neuronal populations and we suggest that it may be more instructive to view RPE cells as an intrinsic part of neuroretinal architecture. Indeed, functionally, RPE cells form an interdependent unit with photoreceptors.
This conceptualisation of the retina, as a single functional unit may help to explain the overlapping molecular control of RPE, photoreceptor and other neural retinal cell differentiation. At the molecular level this differentiation is governed by members of a common pool of transcription factors, the relevant components of which we will now discuss briefly. For a more comprehensive account of transcription factor function the reader is directed to an excellent review by Klassen et al. (2004a) .
The key fate decision for neuroretinal progenitor cells (i.e. non-pigmented retina vs. RPE) is largely determined by the expression of Mitf and Chx10 and the dynamic interplay between them. These transcription factors are essential for proper eye development and mutations in both are associated with micro-ophthalmia (Burmeister et al., 1996; Hodgkinson et al., 1993) .
Mitf is crucial for acquisition of pigmentation (via tyrosinase activity) and maintenance of RPE cell identity. Mutations in the Mitf gene result in an absence of differentiated RPE cells and transdifferentiation of RPE to non-pigmented neural retina Nguyen and Arnheiter, 2000) . The expression of RPE-specific genes such as Mitf and Wnt13 is augmented by extraocular mesenchyme or application of activin A (Fuhrmann et al., 2000) , while a downregulation in the expression of Mitf and other RPE-associated genes (Tfec) can be achieved by misexpression of Chx10 (Rowan et al., 2004) or application of bFGF (Horsford et al., 2005; Nguyen and Arnheiter, 2000) . In agreement with the results of Rowan and colleagues, the bFGF-induced reduction in Mitf expression has been shown to be Chx10 dependent (Horsford et al., 2005) .
Other genes important for acquisition and maintenance of RPE cell fate have been described (Baas et al., 2000; Baumer et al., 2003; Lee et al., 2001; Martinez-Morales et al., 2004 , 2001 West-Mays et al., 1999) and are summarised in Fig. 1 . When differentiating HESCs, good markers of functionally mature RPE cells are RPE65, cellular retinaldehyde binding protein (CRALBP) and monocarboxylate transporter 3 (Turowski et al., 2004) .
Non-pigmented identity of developing retinal progenitor cells is maintained by Chx10, as mutations in this gene (Chx10 or-j/or-j ) cause ectopic Mitf expression and subsequent pigmentation of neural retina (Horsford et al., 2005) . Chx10 is important for the proliferation of non-pigmented retinal progenitors (Burmeister et al., 1996) and the expression of this transcription factor is suppressed by signals that augment Mitf, such as extraocular mesenchyme (Fuhrmann et al., 2000) . Thus, in the developing ocular environment, there is a reciprocal relationship between Chx10 and Mitf transcription levels brought about by opposing gradients of FGF (from surface ectoderm) and BMP-like signals (from extraocular mesenchyme). This results in spatially restricted proliferation of non-pigmented and pigmented progenitor cell populations.
Rod and cone photoreceptors
The molecular control of photoreceptor genesis has been covered extensively elsewhere (Cepko et al., 1996; Harada et al., 2007; Klassen et al., 2004a) and key genes implicated in retinal development are summarised in Fig. 1 . For the purposes of the current review, we will concentrate on the defining characteristics of classical photoreceptors/photoreceptor progenitors which one may look for when attempting to generate these cells from HESCs.
The mammalian retina contains highly specialised photoreceptive neurons, rods and cones, evolved to capture photons and transduce this energy into electrical signals. To achieve this, these cells utilise membrane-bound, G protein-coupled retinylidine proteins that consist of an opsin molecule covalently bonded to a vitamin A-based retinaldehyde chromophore (11-cis-retinal). Rod photoreceptors employ rhodopsin and are specialised to respond optimally to dim illumination, while cones are specialised for vision in daylight, employing short-wavelength (S-opsin), medium-wavelength (M-opsin) or long-wavelength (L-opsin) sensitive opsins. In terms of electrophysiology, photoreceptors are known to hyperpolarise in response to light stimuli.
The Otx-like homeobox gene Crx is essential for the proper development, differentiation and maintenance of cones and rods (Freund et al., 1997; Furukawa et al., 1997) . Two other transcription factors of importance for rod photoreceptor development are neural retina leucine zipper (Nrl) and the nuclear receptor Nr2e3. These molecules are expressed in mature vertebrate rods where they are thought to regulate rod-specific transcription and repress cone-associated gene expression, respectively Mears et al., 2001) . Thus in the absence of Nrl and Nr2e3, the default differentiation of retinal progenitor cells is currently thought to be towards a cone photoreceptor lineage (Roberts et al., 2005) .
In human retina, the first photoreceptor-associated genes are expressed around the developing fovea. Using immunohistochemistry it is possible to detect interphotoreceptor binding protein (IRBP) at foetal week 9, followed by phosphodiesterase beta (PDEB), Crx, Nrl and opsins by foetal week 15-16 (O'Brien et al., 2003) . While a similar sequence of events is found using RTPCR, the later onset of gene expression obtained here most likely reflects the limitations in sensitivity of this method (Bibb et al., 2001; O'Brien et al., 2003) . The molecules that may be useful in defining photoreceptor genesis from ESC cultures are summarised in Fig. 1 .
Human embryonic stem cell (HESC) culture
HESCs are capable of unlimited self-renewal when maintained under appropriate culture conditions and can retain pluripotency indefinitely in vitro prior to differentiation into cell progeny from all three germ cell layers (Amit et al., 2000; Thomson et al., 1998; Zwaka and Thomson, 2005b) . In this section we discuss methods of HESC derivation/maintenance before considering those conditions which appear conducive to derivation of specific ocular phenotypes in Section 4.
Derivation methods
The human blastocyst is a preimplantation multicellular embryonic structure (70-100 cells) consisting of an inner (embryoblast) and an outer (trophoblast) cell mass. The first mammalian ESCs were derived from the inner cell mass (ICM) of mice (Evans and Kaufman, 1981; Martin, 1981) . Non-human primate ESC and HESC cultures were derived somewhat later using mouse embryonic fibroblast (MEF) feeder cells and foetal bovine serum (Reubinoff et al., 2000; Thomson et al., 1998 Thomson et al., , 1995 .
The isolation of ICM cells typically involves the use of enzymes (pronase to remove the zona pellucida) and immunosurgery where the outer trophoblast layer is selectively removed using rabbit anti-human antibodies . Such signals may act cumulatively with time to enhance the ability of HESC lines to differentiate into RPE cells. Over time in vitro, HESCs are selected for their ability to proliferate and to maintain pluripotency, a process that involves, at the earliest stages, epigenetic modifications and at later stages, karyotypic adaptations. We suggest that cellular choices made by HESCs between RPE and photoreceptor cell fate may be influenced by a reciprocal interaction between FGF and BMP/TGFb-like signalling. Those factors implicated in differentiation towards a photoreceptor lineage are shown to the left, while those that may enhance RPE cell derivation are listed in the box to the right. We suggest that a third option to produce photoreceptors could exploit any evolutionarily conserved ability of HESC-derived RPE to transdifferentiate towards retinal lineages. Factors that may be important in this respect are bFGF and IGF-1. For convenience, the boxes at the base of this figure show genes of importance that can be used to identify the respective cell types. Cellspecific transcription factors are shown on the left of each box, while those genes associated with the structure and function of requisite retinal cell types are indicated towards the right.
It should be noted that HESC lines derived from cells of the ICM are not direct in vitro equivalents of ICM cells. Once placed into artificial cell culture environments, ICM cells are exposed to extrinsic cues promoting cell adaptation. For this reason, ESCs can be considered as somewhat of a cell culture artefact, with similarities to early germ cells and primitive ectoderm (Smith, 2001; Zwaka and Thomson, 2005a ).
HESC maintenance
Once derived, HESCs form colonies that are maintained and propagated either on a layer of feeder cells or under feeder-free conditions using suitable extracellular matrix and feeder-conditioned media (Xu et al., 2001) . Following the initial use of foetal bovine serum (Reubinoff et al., 2000; Thomson et al., 1998) , more recent HESC culture techniques utilise knockout serum replacement, together with supplemental bFGF (Enver et al., 2005; Schatten et al., 2005) and/or various extracellular matrix components and activin A . These modifications have been reported to facilitate the maintenance of undifferentiated, pluripotent HESC colonies.
Despite these advances, there is still a significant percentage of spontaneous differentiation in HESC cultures, some of which is likely to be directed towards ocular lineages. In this respect it is interesting to note that MEF cells produce various factors that may promote such differentiation, including BMP, TGFb/activin and IGF-1 (Greber et al., 2007; Prowse et al., 2007 ). An alternative monolayer propogation approach to cell culture has been adopted for mouse ESCs. Through eliminating the incumbent variables associated with co-culture, significant advances have been made in understanding mechanisms of self-renewal and differentiation using this approach (Lowell et al., 2006; Ying et al., 2003) .
Undifferentiated HESCs are characterised by the expression of Stage Specific Embryonic Antigens (SSEA-3, SSEA-4) and the keratin sulphate-associated antigens TRA-1-60 and TRA-181 (Draper et al., 2002) . The key transcription factors required for propagation and transcriptional regulation of HESCs are Oct4, Sox2 and Nanog (Boyer et al., 2005) . It has been suggested that HESCs adopt a strategy of expressing thousands of genes at intermediate levels in order to maintain pluripotency and that the expression of only a subset is maintained following commitment and differentiation towards specific lineages (Golan-Mashiach et al., 2005) .
Adaptation to life in vitro
As illustrated in Fig. 1 , over time in vitro, HESCs undergo processes of adaptation. This adaptation is driven by selection pressures in the cell culture environment and can be broadly divided into two categories. The first category includes epigenetic changes to HESC lines due to modifications in DNA methylation (determining which parts of the genome are expressed), while the second involves karyotypic alterations to individual chromosomes.
To date, methods used to derive and expand HESC lines have been variable and this variability provides tremendous scope for programming differential and stable epigenetic changes into the HESC genome. A recent study examining the DNA methylation profiles of over 2000 genomic loci has addressed this issue in different HESC lines exposed to variable culture conditions (Allegrucci et al., 2007) . The results of this investigation demonstrate that significant epigenetic variations exist between HESC lines from the earliest stages post-derivation and that HESCs inherit further changes over time in vitro. The effect of changing established lines to more clinically suitable serum-free culture conditions also contributed significantly to epigenetic instability. In a separate study, karyotypically silent epigenetic changes have been reported in terms of failure to inactivate one copy of the X chromosome in a female HESC line (Enver et al., 2005) .
The clear implications of these studies are that existing HESC lines may have inherited epigenetic modifications to their genomes that subsequently enhance or preclude the chances of successful derivation of target cell types such as RPE cells and photoreceptors. This underscores the need to generate fresh HESC lines for use in therapeutic applications.
The second type of HESC adaptation detailed in Fig. 1 is karyotypic modification, which occurs as a result of protracted in vitro expansion. This phenomenon is characterised by stereotyped adaptive changes in the karyotype of HESC lines, with a selection for aneuploid cells and common alterations in defined chromosomes (Draper et al., 2004; Enver et al., 2005) . Such modifications have been suggested to provide selective advantages for long-term proliferation of pluripotent cells in vitro (Draper et al., 2004) . Unlike the epigenetic changes detailed above, karyotypic changes commonly occur in relatively high passage ''adapted'' HESC lines (Enver et al., 2005) .
Differentiation of embryonic stem cells (ESCs) towards ocular lineages
In the absence of appropriate intercellular signals specifying alternate cellular fates, ESCs are directed towards neuronal differentiation (Hemmati-Brivanlou and Melton, 1997; Munoz-Sanjuan and Brivanlou, 2002; Tropepe et al., 2001 ), a phenomenon thought to involve autocrine/ paracrine FGF and Notch signals (Lowell et al., 2006; Ying et al., 2003) .
Different culture techniques exist to maximise induction of neural progenitor cells from HESCs Plachta et al., 2004; Reubinoff et al., 2001; Ying et al., 2003; Zhang et al., 2001 ). These methods result in precursor cells (which include radial glia) capable of full neuronal differentiation and generally employ non-adherent cultures of ESC-derived embryoid bodies and media substituted with retinoic acid Plachta et al., 2004) or elevated levels of bFGF (Reubinoff et al., 2001; Zhang et al., 2001) . Other methods employing Noggin-mediated inhibition of BMP signalling have proved useful in the derivation of non-pigmented midbrain dopaminergic cells (Sonntag et al., 2006) .
The apparent ease by which neural progenitor cells are derived from cultures of HESCs may partly explain the ability of some of these cells to differentiate towards neuroretinal lineages. We will now consider the existing evidence for ocular cell derivation from HESCs with special emphasis on RPE and photoreceptor genesis.
The lens and RPE
These two ocular lineages are placed under the same heading in this review, not due to their similarity in terms of conventional embryological origin but due to the intriguing observation that these two structures appear simultaneously under uniform conditions of HESC culture. Although melanocytes have been known to form from mouse ESCs for some time (Yamane et al., 1999) , it is only more recently that pigmented cells derived from mouse (Hirano et al., 2003) and primate ESC lines (Kawasaki et al., 2002; Ooto et al., 2003) have been identified as RPE cell-like.
Kawasaki and colleagues first used a culture method based on stromal cell-derived inducing activity (SDIA) from mesenchymal bone marrow cells (PA6 stromal cells) to neuralise mouse ESCs and generate dopamine neurons (Kawasaki et al., 2000) . The same investigators later used a similar method to derive pigmented, Pax6 positive cells from primate ESC cultures (Kawasaki et al., 2002) . In this study, the first pigmented cells were observed following 3 weeks of co-culture with PA6 cells. Two subsequent studies employing SDIA to induce RPE cells from mouse and primate ESCs also reported the simultaneous derivation of crystalline-positive lentoid bodies (Hirano et al., 2003; Ooto et al., 2003) . The lentoid body production was shown to be maximal at high levels of bFGF and high seeding densities of ESCs (Ooto et al., 2003) . One possible (and entirely feasible) explanation for the coincidence of RPE and lentoid bodies in these studies is that the freshly derived primate RPE cells are transdifferentiating into lens tissue in vitro. Such a phenomenon is characteristic of the RPE in lower vertebrates (Stroeva and Mitashov, 1983) and some evidence exists for the formation of lentoid bodies in cultures of neural retina and RPE isolated from human foetal eyes (Okada et al., 1977; Yasuda et al., 1978) . The possibility that HESC-derived RPE cells can transdifferentiate into lens tissue in vitro needs further investigation.
More recently, it has been shown that Wnt2b signalling can increase the production of RPE cells from SDIA-cultured mouse ESCs (Aoki et al., 2006) . It should be noted that both studies on mouse ESCs include the addition of foetal calf serum to the PA6 stromal co-culture medium (Aoki et al., 2006; Hirano et al., 2003) . The most recent modification to the SDIA induction protocol involves dispensing with these cells entirely and using instead the matrix layers of human amniotic membrane (Ueno et al., 2006) . Again, this method results in production of lentoid bodies coincident with HESC-derived pigmented cells, and may prove to be an important innovation for future derivation of clinically applicable RPE cells. At present, the exact molecular nature of SDIA and amniotic membrane matrix signals are unknown; however, SDIA is thought to involve molecules on the surface of the PA6 stromal cells (Kawasaki et al., 2000; Ueno et al., 2006) .
The RPE phenotype of pigmented HESC-derived cells has been confirmed by a comprehensive recent study (Klimanskaya et al., 2004) . These authors utilised a comparative transcriptomics approach to assess the similarities between HESC-derived RPE cells, human foetal RPE and several human RPE cell lines, including the well-characterised ARPE19 cells. They found that HESC-derived RPE not only express RPE-specific genes involved in melanin production and the visual retinoid cycle (RPE65) but that they are actually more similar to human foetal RPE (in terms of transcriptional profile) than the other human RPE cell lines tested. This study also provides evidence that HESC-derived RPE cells can phagocytose latex beads and express two RPE-associated genes at the protein level: CRALBP and bestrophin. The RPE cells in the above study were derived by overgrowth of HESCs on MEF feeders, with pigmentation appearing over a period of 2-6 weeks. We have similar experience with HESC lines derived in Sheffield (see Fig. 2 ), and this time course corresponds well with that for RPE pigmentation during human retinal development (O'Rahilly, 1975) . The reports by Robert Lanza and colleagues that RPE cells can be established from numerous HESC lines, with protracted time in culture, and little manipulation to standard MEF co-culture culture conditions (Klimanskaya et al., 2004; Lund et al., 2006) , together with our own observations of RPE derivation from Sheffield HESCs (see Fig. 1 ), suggest that for many HESC lines, derivation of RPE cells may be spontaneous under in vitro MEF co-culture conditions. As noted previously, the culture environment produced by MEFs contains factors that may predispose cells to RPE differentiation (Prowse et al., 2007) . However, it is anticipated that a greater understanding of this phenomenon will allow us to increase the efficiency of RPE cell differentiation significantly from HESCs (Fig. 1) .
Retinal progenitors and photoreceptors
To date, the literature pertaining to the derivation of photoreceptor progenitors from ESCs is somewhat more limited than that for RPE derivation and evidence for production of fully functional photoreceptors is still lacking. However, several important studies highlight the exciting prospect that we may be able to produce photoreceptors from HESC culture some time in the near future.
The first of these studies used mouse ESCs and shows that ESC-derived neural progenitor cells express regulatory genes that are important for differentiation along a photoreceptor lineage (Zhao et al., 2002) . Zhao and colleagues show that HESC-derived neural progenitor cells (derived using retinoic acid or insulin, transferrin and selenium plus bFGF induction methods) express markers consistent with retinal progenitor cells (nestin, NOTCH1 and Pax6) and that they can be driven by epigenetic cues towards bipolar (Chx10/PKC positive) and photoreceptor progenitor (Rx, Crx and Nrl positive) cells by co-culture with postnatal day 1 rat retinal cells. The potential of these mouse ESCderived progenitor cells to produce cells expressing markers of mature rod photoreceptors (rhodopsin kinase, arrestin, peripherin and IRBP) was revealed after extended periods of co-culture with primary rat retinal cells.
A subsequent study with mouse ESCs has gone some way to defining those factors that are important for photoreceptor progenitor derivation (Ikeda et al., 2005) . Here, the authors used a serum-free culture medium enriched with Dkk1 and LeftyA, (inhibitors of Wnt/bcatenin and nodal signalling, respectively), to derive what appear to be retinal progenitor cells. These cells are distinguished by their co-expression of Pax6 and Rx transcription factors together with Ki67, a protein required for engagement in active phases of the cell cycle (Schluter et al., 1993) . Again, these progenitor cells were shown to be capable of producing rhodopsin-positive cells when co-cultured with embryonic mouse retinal cells (Ikeda et al., 2005 ).
An interesting observation taken from the study by Ikeda and colleagues regards the Rx/Pax6 positive retinal progenitor derivation. Specifically, optimal production of retinal progenitor cells is achieved by addition of foetal calf serum (FCS) and activin to the serum-free medium containing Dkk1 and LeftyA (increasing retinal progenitor numbers as a percentage of the cell colony from <5% to >25%), with half this effect attributable to the addition of FCS alone (Ikeda et al., 2005) . Importantly, this data may be instructive in explaining other reports of photoreceptor-specific gene expression when deriving RPE and len- toid bodies from mouse ESCs (Aoki et al., 2006; Hirano et al., 2003) . In both of these latter studies, FCS was used in the culture media and this factor may have been instrumental in the results these investigators report.
The most recent and important advance in our understanding of retinal progenitor cell derivation from ESCs has come from a study on the H1 HESC line (Lamba et al., 2006) . Here, the use of Noggin and Dkk-1 was used to precipitate neural induction in H1 cells, which are assumed to be of high passage and to contain karyotypic adaptations (although no karyotyping was undertaken by these investigators). Based on the developmental literature, the authors took the novel step of combining Noggin and Dkk-1 with IGF-1, in the absence of FCS.
Despite the fact that the H1 cell line has been exposed to FCS at early stages in its derivation (Thomson et al., 1998) , thereby predisposing these cells to a retinal phenotype, Lamba and colleagues provide compelling evidence that their novel protocol is capable of significantly enhancing HESC gene expression for retinal progenitor cell markers, including those specific for photoreceptors (Crx, rhodopsin, S-opsin and recoverin). However, as indicated by the 30% increase in Six3 and Crx gene expression after 1 week of retinal determination conditions, a small but significant part of this effect may be mediated by the addition of bFGF during the retinal progenitor expansion phase, since there is an established role for bFGF in promoting differentiation (as measured by opsin expression) of retinal progenitor cells in vitro (Hicks and Courtois, 1992) .
Retinal cells derived from H1 HESCs are reported to express recoverin, rhodopsin and Nrl when in association with degenerate mouse retinal explants (Lamba et al., 2006) . Although this data is encouraging, it will be important to control for artefactual staining caused by microglial cells that have been shown to be active in retinal explants Dick, 2003, 2004) . It is also not clear from the report by Lamba and colleagues if the HESC-derived retinal progenitor cells have exited active phases of the cell cycle once in association with retinal explants. This is an important consideration in any future studies aiming to derive retinal progenitor cells from HESC cultures that have previously been selected in vitro for their capacity to proliferate and remain pluripotent. Additionally, it would appear imperative to avoid the transplantation of proliferative, recoverin-positive cells, given the clear implication of this molecule in cancer-associated retinopathy (Polans et al., 1995) .
Retinal transplantation to replace RPE and photoreceptors
A substantial body of work has laid the foundations for experimental approaches to the assessment of cellular transplantation in animal models of retinal degeneration, with proof of principle for the potential of stem cell transplantation deriving from studies using RPE, photoreceptor progenitors and photoreceptors. This work will only be described briefly here since it has been the topic of several other reviews (Aramant and Seiler, 2004; Coffey et al., 2000; Delyfer et al., 2004; Klassen et al., 2004a; Lund et al., 2001b Lund et al., , 2003 Young, 2005) .
RPE transplantation
Human RPE disorders include age-related macula degeneration and some forms of retinitis pigmentosa and they lead to secondary loss of photoreceptors. The first RPE transplant studies were reported in the late 1980s (Li and Turner, 1988; Lopez et al., 1989) where RPE cells were transplanted into the dystrophic RCS rat. This rat has a defect in the RPE cells, which eventually leads to photoreceptor cell death (D'Cruz et al., 2000) and makes it a suitable animal model for many RPE transplantation studies. Transplantation of freshly prepared RPE cells during the first month of life preserves photoreceptors (Castillo et al., 1997; Li and Turner, 1991; Little et al., 1996) and maintains visual function (Whiteley et al., 1996) . In order to identify a more widely available source of RPE cells, ARPE 19 cells (a spontaneously immortalised human RPE cell line) have been used as donor cells and they have produced similar results (Coffey et al., 2002; Gias et al., 2007; Girman et al., 2003; Lund et al., 2001a; Sauvé et al., 2006) . These cells also prevent the onset of the secondary degenerative events (Wang et al., 2005) and have been shown to enhance visual function in a recent clinical trial (Sieving et al., 2006) . Encouragingly, the increase in visual acuity reported in this phase I clinical trial did not require the transplantation of new photoreceptors.
Photoreceptor transplantation
Although photoreceptor preservation has been achieved by administering growth factors to the eye (i) by direct injection (Faktorovich et al., 1990; LaVail et al., 1998; Masuda et al., 1995) or (ii) by gene therapy (Buch et al., 2006; Liang et al., 2001; McGee Sanftner et al., 2001) or (iii) by transplantation of cells (e.g. Schwann cells) producing retinally relevant growth factors Lawrence et al., 2004 Lawrence et al., , 2000 , replacement of photoreceptors is a much more challenging prospect because of loss of connectivity between neurons and potential for glial scarring responses. In a pioneering study by Kwan et al. dissociated retina (taken from postnatal day 7-9 mice of a congenic strain) was transplanted into the subretinal space of 6-8-week-old rd1 mice (Kwan et al., 1999) . Large areas of photoreceptors with outer segments were reconstituted in these mice and they integrated sufficiently to drive a simple light/dark discrimination test. Improvements in visual function have also been reported following transplantation of multipotent retinal progenitor cells derived from GFP expressing mice (Klassen et al., 2004b) . Most recently, a detailed study by MacLaren et al. has extended upon the initial work using dissociated retina, confirming the ability of partially differentiated photoreceptor progen-itor cells to restore at least one subcortical visual function . Other transplantation strategies include the grafting of retinal sheets, with or without attached RPE, into the eyes of various rodent models of retinal degeneration (Aramant and Seiler, 2004) .
6. Transplantation studies using ESC-derived cells
Tumour formation by naïve ESCs
A potential for continued proliferation of HESCderived neural progenitors clearly exists, although there has been only one report to date that transplantation of neurally selected mouse ESCs into the rodent retina induces tumour formation (Arnhold et al., 2004) . Recent studies utilising different protocols to neuralise mouse (Meyer et al., 2004 (Meyer et al., , 2005 and primate/human (Banin et al., 2006; Coffey et al., 2005; Haruta et al., 2004; Lund et al., 2006) ESCs prior to transplantation have found no comparable evidence of tumour formation, despite persistent failure of subpopulations of cells to exit the cell cycle.
Pre-transplantation differentiation of ESCs
To date, the only reports of mouse ESC and HESCderived neural progenitor integration into the retina have involved the pre-differentiation of ESCs prior to grafting. Studies demonstrating the integration and differentiation of mouse ESCs following transplantation into the vitreal cavity of retinal degenerate mice used a method of neuralisation which involves the withdrawal of leukaemia inhibitory factor (LIF), embryoid body formation and the addition of retinoic acid (Meyer et al., 2004 (Meyer et al., , 2005 . In these studies an absence of tumour formation was reported with survival time points post-grafting of up to 16 weeks.
The integration of HESC-derived neural precursor cells has been demonstrated following grafting into the neonatal rat retina (Banin et al., 2006; Coffey et al., 2005) . Banin and colleagues used a neuralisation procedure employing 10% FCS, Noggin, B27 supplement, EGF and bFGF to produce cells capable of integration into the postnatal rat retina. We also reported this phenomenon (Coffey et al., 2005) , using a different method of neuralisation which employed propagation of neural progenitor cells as neural rosettes in serum-free medium supplemented with bFGF, insulin, transferrin and selenium (Zhang et al., 2001) . Like Banin and colleagues, we could detect no teratoma formation following transplantation of neuralised HESCs. An example of retinal integration of GFP-labelled H7 HESC-derived neural progenitor cells into the host rodent retina is shown in Fig. 3 .
Two transplantation studies carried out with RPE cells derived from non-human primate ESCs (Haruta et al., 2004) and HESCs have indicated survival of pigmented cells in vivo with an absence of tumour formation. Both neuralisation methods involved the addition of FCS in the post-RPE isolation expansion phases.
The SDIA from PA6 cells was used to derive RPE from non-human primate ESCs (Haruta et al., 2004) , while standard MEF cell culture was sufficient to derive human RPE suitable for transplantation into rodents (Klimanskaya et al., 2004; Lund et al., 2006) .
Retinal integration by grafted ESC-derived progenitor cells
At present, the transplantation and integration of ESCderived neural progenitor cells into the mammalian retina has only been reported in a handful of studies in rodent models. In the first of these Meyer and colleagues grafted mouse ESC-derived cells into the vitreal cavity of 5-weekold rd1 mice, a stage when outer retinal degeneration (rods and/or some cones) is maximal in these animals. The majority of grafted cells were found to lie along the inner limiting membrane of host retina and to extend small cellular extensions into the vitreous. Cells in this location commonly expressed the glial marker glial fibrillary acidic protein (GFAP), as did reactive Mü ller cells of the host retina. In regions where ESC-derived cells had integrated into the inner plexiform layer there was evidence that these cells could extend varicosity-laden processes and express the neuronal marker bIII tubulin (Meyer et al., 2004) .
The second study utilised the same injection method (intravitreal) in another strain of retinal degenerate mouse (mnd mice) and showed comparable results to the first study in terms of inner retinal integration and expression profile of ESC-derived grafted cells (Meyer et al., 2005) , although the processes of integrated cells were occasionally observed at the level of the outer plexiform layer. However, no really credible evidence was presented in this study for the expression of photoreceptor-specific markers by grafted ESCs. In both studies by Meyer et al. the failure to assess staining with single confocal optical slices makes it somewhat difficult to interpret the true extent of retinal marker expression by grafted cells, although these ESC-derived neural progenitors are clearly capable of expressing generalised neural markers (bIII tubulin, calretinin and PKCa) within the host retinal environment. As will be discussed further below, the identification of grafted cells expressing rhodopsin (Meyer et al., 2005) may be based on a staining artefact derived from host phagocytes (microglia and/or macrophages).
Original attempts at xenografting human neural progenitor cells (derived from foetal cortex) into the rat retina have shown little evidence of integration of these cells into host tissue (Mizumoto et al., 2001 ). The major explanation given for this by the authors was that fundamental species differences exist in terms of requisite molecular cues and that this leads to a lack of integration when grafting human cells into rodent retina. However, data from two recent studies (Banin et al., 2006; Coffey et al., 2005) indicate that this incompatibility may be restricted to the cell type used and not species differences per se. In this regard the HESCderived neural progenitors transplanted into postnatal rat retina appear to behave in a similar fashion to adult rat hippocampal progenitor cells (Young et al., 2000) .
In a study where HES-1 HESCs were used to derive neural progenitors for transplantation into the vitreous cavity and/or subretinal space of neonatal and adult rats (Banin et al., 2006) , evidence was found that these human cells were capable of integrating into the inner layers of host rodent retina. Simultaneously, using different conditions to neuralise the H7 HESC cell line, we reported the same phenomenon (Coffey et al., 2005 ). An example of this HESC-derived progenitor integration is shown in Fig. 3 , where we also employ a simple histological control method to identify host phagocytes. Without this control we have found significant problems with a fluorescence staining artefact emanating from host microglia and macrophages and fear that this may account for some of the in vivo histological data presented in recent publications on retinal stem cell transplantation (Canola et al., 2007; Coles al., 2004) . As such, in the absence of appropriate histological controls, the data presented by Banin and colleagues, that grafted HESC-derived progenitors are capable of expressing S-opsin in the subretinal space, should be interpreted with caution. If verified, this potentially exciting finding would be a major advance. The HES-1 cells used by Banin and colleagues certainly show the potential to express this short-wavelength sensitive opsin post-neuralisation (Banin et al., 2006) , a phenomenon we have also observed in both H7 and SHEF1 HESCs (unpublished data). Functional (electrophysiological, behavioural and imaging) studies will be needed to confirm the physiological significance of any in vivo opsin expression by HESC-derived cells.
The first study to address the potential of ESCs to preserve photoreceptors used neural precursor cells derived from mouse ESCs injected into the subretinal space of dystrophic RCS rats (Schraermeyer et al., 2001 ). Significant photoreceptor preservation was observed. In terms of functional studies on HESC-derived RPE cells in vivo, further progress has also been made (Haruta et al., 2004; Lund et al., 2006) . The functional measure used to test the capacity of non-human primate-derived RPE cells to rescue photoreceptors was the optokinetic headtracking response (Haruta et al., 2004) , which has previously been shown to correlate well with host photoreceptor preservation and to be a sensitive and reliable measure of visual system function in RPE transplantation studies on RCS dystrophic rats (Coffey et al., 2002; Lawrence et al., 2000) . Haruta and colleagues also provided evidence for phagocytosis of rod outer segments by the grafted primate-derived RPE, an important observation, which may be strengthened by subsequent experiments controlling for host phagocyte activity (Haruta et al., 2004) .
The most recent study using HESC-derived RPE grafting in the RCS rat model confirms the findings of Haruta and colleagues with primate ESC-derived RPE; however, in this instance, visual function was more comprehensively assessed with a range of standard tests . Lund et al. also used an antibody to human nuclear antigen to confirm the identity of the grafted cells, so there could be no confusion with host inflammatory cells. However, they did not present any evidence of phagocytosis, so it is possible that the photoreceptor rescue observed could be due to growth factor release, as demonstrated when non-phagocytic Schwann cells are injected into the same animal model (Lawrence et al., 2000 (Lawrence et al., , 2004 . Importantly, a limited degree of photoreceptor preservation and functional improvement can be achieved via sham-injections, which include fibroblast-only controls (Lawrence et al., 2000) . This is particularly pertinent to studies on primate ESCderived RPE cells, which may also contain residual mouse mesenchymal PA6 stromal or MEF cells. Thus, what needs to be confirmed by subsequent in vivo studies on HESCderived RPE cells is the true nature of host photoreceptor preservation i.e. phagocytosis versus trophic-mediated rescue.
We will now consider the various molecular cues that HESC-derived cells (RPE, neural and photoreceptor progenitors) will encounter when transplanted into the retinal environment of mammals. The host cellular environment of the degenerating retina may contain barriers to cellular integration. It is hoped that a thorough examination of this issue will enhance the outcome of future retinal transplantation studies examining the functional capacity of ESCderived retinal cells in vivo.
Obstacles to cellular replacement strategies
In many ways, the eye is an ideal organ to assess transplant success since techniques are available to monitor graft survival function and, in the event of a serious adverse reaction, the eye can be extirpated. Transplants to slow the loss of existing neurons in the degenerating retina may be the first useful method for maintenance of some degree of vision. However, the ultimate goal is replacement of lost neurons since, except for specific regions of the CNS, little true regeneration occurs in the adult during aging or following disease or injury. The identification of progenitor cells in the CNS (Gage, 2000) has raised the hope of stimulating endogenous repair mechanisms (Lie et al., 2004; Parent, 2003) but they seem to be largely inactive in the repair process either because the number of progenitor cells is insufficient or because of inhibitory mechanisms within the host tissue. Manipulation of embryonic stem cells to produce desired replacement cells is a potentially viable treatment for cell loss. However, the tissue environment during development is very different from that of the mature CNS. Radial glia, rather than astrocytes, guide growing axons to their targets with specific molecular cues (Harada et al., 2007) which are downregulated with time. Astrocytes invade the tissue once connections have formed and at this point the tissue environment becomes largely non-permissive to neuronal cell migration and axon growth. Thus, stem cells transplanted into the developing retina appear to migrate well, while those grafted into the adult retina do not (Nishida et al., 2000; Takahashi et al., 1998) .
There are many important elements in retinal and CNS biology to consider in the attempt to solve the conundrum of tissue repair. Fig. 4 is a simplified diagram showing the interaction between cell types in the diseased or damaged retina and the protective/inhibitory cellular events that may compromise HESC integration and survival.
Cytostatic signals in adult retina
Although HESC-derived neural progenitor cells can migrate into the inner retina following intravitreal injections (Banin et al., 2006; Coffey et al., 2005) , they seldom migrate further than the inner nuclear layer. This may, for example, be due to the absence of suitable migratory substrates (see Section 7.4), but cytostatic signals may also be responsible. Candidates for cytostatic signalling include DOPA (Ilia and Jeffery, 1999) and dopamine (Kralj-Hans et al., 2006) , produced from the dopaminergic interplexiform cells at the border of inner nuclear layer (INL) and the inner plexiform layer (IPL). Dopamine is known to inhibit neuronal growth cone motility (Lankford et al., 1988) .
Another possible cytostatic signal in the mature retina is TGFb2, produced by inner retinal neurons, which has been identified as a potent inhibitor of progenitor cell and Mü ller cell proliferation (Close et al., 2005) . TGFb has other potentially negative effects. For instance, it is a key regulatory molecule increasing proteoglycan synthesis, an inhibitory substrate (see Section 7.5.2 and Fawcett and Asher, 1999) and it also upregulates GFAP expression after CNS injury (Logan et al., 1994) .
Retinal remodelling in disease
The eventual outcome of retinal diseases involving photoreceptor loss is remodelling of the vasculature and loss or migration of second and third order retinal neurons. This was originally described in animal models of retinal dystrophy (the RCS rat (Villegas-Perez et al., 1998) and the rd mouse (Strettoi and Pignatelli, 2000; Wang et al., 2000) . Elegant studies by Jones et al. (Jones and Marc, 2005; Jones et al., 2003) showed that the remodelling outcomes fall into three major categories: (i) Müller glial cell hypertrophy and the formation of a glial seal between the retina and the retinal pigment epithelium; (ii) migration of inner retinal neurons and (iii) the formation of new connections between the remaining inner retinal neurons. In addition to the physical neuronal remodelling that accompanies retinal degeneration there are also reductions in the levels of dopamine (Vugler et al., 2007) , which has been implicated in visual acuity and spatial contrast functions of the vertebrate retina (Djamgoz et al., 1997) . However, it has been postulated that the neurite sprouting, aberrant axonal connections and nuclear kinesis observed in cone photoreceptors in aged human retinae and in retinae with the dry form of AMD represents a recapitulation of some key features of development (Pow and Sullivan, 2007) . These remodelling events highlight the degree of plasticity that remains within the mature retina although they may prove a challenge for transplantation studies at least at end stages of disease. Early transplant intervention can prevent the onset of the inner retinal changes (Wang et al., 2005) .
Stem cells, however, should be differentiated prior to transplantation since undifferentiated cells integrating into the host environment may destabilise the retina even further, either by tumour formation, the formation of inappropriate connections or by adding to the glial scar.
Remodelling in the brain
Reactive responses to injury are not confined to the retina. Axonal loss and consequent loss of connectivity can lead to synaptic remodelling in the brain. It has been known for many years (Lund and Lund, 1971; Raisman and Field, 1973 ) that when axons degenerate and synapses are vacated, local axons sprout to occupy the post-synaptic sites, so even if regenerated axons reach their target areas in the brain there may be no sites for them to re-colonise. However, optimistically for transplantation studies in general, it has been shown that endogenous sprouting of local axons after a lesion does not preclude reinnervation of some of the denervated sites by embryonic transplants (Field et al., 1997 ). Nevertheless, it is possible that the remaining inappropriate connections may still interfere with the read-out of meaningful information (Turner et al., 2005) .
Evidence for changes in visual centres in the brain can be seen in rat models of retinal degeneration or disease. For example, induction of glaucoma in rats leads to significant neuronal cell death in the lateral geniculate nucleus within one month of induction . Similar central changes have been identified in human glaucoma (Gupta et al., 2006) . In the dystrophic RCS rat, loss of ganglion cells results in patchy loss of calretinin-positive neuronal fibres in the superior colliculus, lateral geniculate and olivary pretectal nuclei (Vugler and Coffey, 2003) .
In addition to anatomical changes, plastic changes have also been observed in the information processing regions of visual cortex. Retinotopic reorganisation has been shown to occur in cats and monkeys within minutes of a retinal lesion and remains after several months (Gilbert and Wiesel, 1992) . Also in mice, when retinal input is disrupted during the critical period of development, plastic changes in the ocular dominance distribution (Drager, 1978; Gordon and Stryker, 1996) and the retinotopic map (Cang et al., 2005) can be induced. Perhaps surprisingly, unilateral grafting of cells to the dystrophic RCS rat retina resulted in much stronger, better tuned cortical responses to light from the unoperated eye (Girman and Lund, 2005) , even though the anatomy of that eye resembled that of an agematched dystrophic eye. Additionally, in the same animal model, retinotopic changes have been observed (Girman et al., 2003) and relatively small areas of photoreceptor rescue can elicit large areas of cortical activity months after transplantation (Gias et al., 2007) . Cortical reorganisation of visual processing has also been observed in human subjects with long-term macular degeneration (Baker et al., 2005) . Some of the changes observed in processing visual information could be due to changes in the functional connectivity of cortical horizontal connections (Gilbert and Wiesel, 1992) .
In conclusion, it would seem that, provided transplantation occurs at an early stage of disease onset, before retinal remodelling is too advanced, the visual cortex appears to have the capacity to maximise any visual signals it receives, although inappropriate connections could still interfere with the final visual read-out.
Migration of grafted cells
During development, cell migration occurs primarily along radial glia (Rakic, 1971) or tangentially along glial fibres or pre-existing nerve fibre tracts or along pathways that are not obviously cellular. Most of these pathways are lost as the CNS matures. Stem cells must be able to migrate through the mature tissue environment. In order to do this they must produce tissue or matrix-digesting enzymes, for example, metalloproteinases (Lee et al., 2006; Muir et al., 2002; Suzuki et al., 2006) and/or find suitable migratory substrates. A recent study (Zhang et al., 2007) has shown that matrix metalloproteinase-2 is released when retinal progenitor cells are transplanted into the retina. Other molecules which promote cellular migration and axon pathfinding include polysialylated neural cell adhesion molecule, PSA-NCAM (Brittis and Silver, 1995) and collapsing response-mediated protein 4 (TUC-4), a growth cone signalling molecule (Quinn et al., 1999) . These molecules have been implicated in the migration of immature neurons in the adult brain (Nacher et al., 2000; Seki, 2002) and polysialic acid is involved in the migration of olfactory bulb precursors (Hu et al., 1996; Rousselot et al., 1995) . A null mutation for NCAM or deletion of the polysialic moiety results in migratory defects (Ono et al., 1994) . Brain-derived precursor cells (RN33B) have been found to migrate along the sublaminae of the IPL using the extracellular migration cues PSA-NCAM and TUC-4 (Wojciechowski et al., 2004) . Signalling by inflammatory cytokines at the site of injury has also been identified as a potential migratory stimulus (Belmadani et al., 2006; Imitola et al., 2004 , see Section 7.6). 
. Mü ller cells and gliosis
Astrocytes and oligodendrocytes have been shown to be potent inhibitors of regeneration (Fawcett and Asher, 1999) . Within the retina, there are no astrocytes and no oligodendrocytes. This should make the retina a less challenging environment for regeneration or for transplant integration. This is not the case. Although astrocytes are confined to the vitreal surface, there is a resident population of glia, the Mü ller cells which span the retina. They maintain tissue homeostasis and after injury produce neuroprotective growth factors and antioxidants (Frasson et al., 1999; Wahlin et al., 2000) which may be beneficial to neuron survival, yet in more advanced stages of gliosis their homeostatic function may be compromised leading to excitotoxic damage and water and ion inbalance . Like astrocytes, these cells do not usually express GFAP, but when the retina is damaged by injury or disease they become activated, possibly by microglia (Harada et al., 2002) , hypertrophy and express GFAP as part of a gliotic response (Bignami and Dahl, 1979; Bringmann et al., 2000; Bringmann and Reichenbach, 2001; Eisenfeld et al., 1984; Fan et al., 1996; Iandiev et al., 2006; Jones and Marc, 2005; Sethi et al., 2005; Wu et al., 2003) . Ciliary neurotrophic factor (CNTF) released by injury may further amplify GFAP expression (Fischer et al., 2004) . The gliotic response often occurs over a wide area, especially in a degenerating retina. It may reflect an attempt to stabilise the retina because of neuronal loss (Jones and Redpath, 1998) but it may also interfere with both photoreceptor outer segment regeneration and formation of intraretinal synaptic connections.
GFAP (and vimentin, another intermediate filament protein) appear to contribute to the inhibitory environment, since retinal cells (derived from P0 mice) grafted into the retina of adult double GFAP-vimentin knock-out mice migrated and integrated well (Kinouchi et al., 2003) . In particular, axons could be seen penetrating the optic nerve head and the optic nerve. Similarly, axon regrowth was observed in bcl-2tg mice and to a lesser extent in wild type mice after treatment with L-alpha-aminoadipate, an astrocyte toxin (Cho et al., 2005) . If intermediate glial filaments could be transiently removed, then perhaps transplantation outcomes might be greatly improved (Quinlan and Nilsson, 2004) . However, earlier studies (Kruger et al., 1986) have shown that scar formation can be suppressed to some extent by embryonic cell grafts and it is possible that this property may be shared by HESCs (Zhang et al., 2007) .
The outer limiting membrane, composed of adherens junctions between Mü ller cells and photoreceptor inner segments, may also provide a barrier to cellular integration (Rich et al., 1995) .
Mü ller glia release vascular endothelial growth factor, VEGF (Eichler et al., 2004) and metalloproteinases (Giebel et al., 2005) which may induce vascular remodelling and impairment of tight junctions resulting in blood-retinal barrier loss and vessel leakage which may expose the grafted cells to immune surveillance (see Section 7.6.2).
Extracellular matrix
In the brain, sulphated proteoglycans, produced by reactive astrocytes have been identified as inhibitory to axon extension and possibly cell migration (Asher et al., 2000) . Use of enzymes to digest these matrix components has resulted in enhanced neuronal regrowth and restoration of function (Bradbury et al., 2002; Moon et al., 2002) . Sulphated proteoglycans have also been identified in the retina, the optic nerve head and optic nerve. 7.5.2.1. Interphotoreceptor matrix (IPM). The IPM, which surrounds both rods and cones, contains chondroitin-6-sulphate (Hollyfield et al., 1999) and, in humans, chondroitin sulphate is uniquely associated with cone matrix sheaths (Hageman and Johnson, 1987; Johnson and Hageman, 1991; Kuehn and Hageman, 1999) . The IPM forms a structural and molecular link between photoreceptors and the retinal pigment epithelium (RPE), maintaining adhesiveness between the RPE and photoreceptors (Kuehn and Hageman, 1999) . Cells transplanted into this environment may not integrate well. Enzymes which digest elements of the IPM may improve integration, although they may also induce retinal detachment (Yao et al., 1990) .
Relatively few stem cell transplant studies have shown significant migration into the outer nuclear layer (ONL) and the IPM may be an inhibitory component if the donor cells lack suitable matrix-digesting enzymes. 7.5.2.2. Glial sources of inhibitory matrix components. The source of sulphated proteoglycans within the retina is not clear. However, neurocan (a form of sulphated proteoglycan) has been found to be co-expressed with GFAP in the ischaemic retina (Inatani et al., 2000) , suggesting that Mü ller glia may be involved and it has also been described in the retinae of dystrophic RCS rats (Zhang et al., 2003) and rd1 mice . 7.5.2.3. Optic nerve head, lamina cribrosa and optic nerve. Replacement of retinal ganglion cells, RGCs (see the excellent review by Harvey et al. (2006) ) lost by disease (e.g. glaucoma) would require the donor cells to regrow axons through the inhibitory environment of the reactive optic nerve head/lamina cribrosa and the optic nerve (Hernandez, 2000) . Specific matrix changes have been described in rodents after increased intraocular pressure (Guo et al., 2005) and in patients with glaucoma (Hernandez, 2000) . For instance, increased amounts of autoantibodies recognising glycosaminoglycans of the optic nerve head (ONH) have been identified (Tezel et al., 1999) . Age-related changes in sulphated proteoglycans have also been observed in the lamina cribrosa of humans (Sawaguchi et al., 1993) . Reactive astrocytes in the ONH may synthesise other extracellular matrix proteins such as tenascin and laminin which will contribute to microenvironment remodelling and may further inhibit the regrowth of axons into the optic nerve environment (Hernandez, 2000) .
The optic nerve is composed of astrocytes and oligodendrocytes, the latter being another cell type that has inhibitory properties (Bandtlow et al., 1990; Fawcett et al., 1989) producing inhibitory molecules such as Nogo (Chen et al., 2000) and myelin-associated glycoprotein, MAG (Mukhopadhyay et al., 1994) . Embryonic stem cell fibres would either have to have the capacity to grow through this environment or else be transplanted in combination with permissive substrates (see Harvey et al., 2006) . 7.5.2.4. Implications for transplantation of ESCs and progenitor cells. Undifferentiated ESCs transplanted into a highly reactive (gliotic) environment are more likely to give rise to glia rather than neurons, for example, when ESCs were grafted into spinal cord contusion lesions (McDonald et al., 1999) . Yang et al. (2002) also found that the majority of retinal progenitor cells became glia after transplantation. Neural stem cell-like clone cells, transplanted into retinae of neonatal or adult mice with targeted rapid retinal ganglion cell depletion, integrated well but the cells failed to develop into the RGC phenotype (Mellough et al., 2004) . This again suggests that ESCs or progenitors must be differentiated prior to transplantation.
The fact that embryonic neurons have been able to make appropriate connections in the adult brain, e.g. E17 neurons are able to migrate and differentiate appro-priately after targeted neocortical cell death in adult mice, suggests that some pathway cues can be recapitulated in the adult environment (Mellough et al., 2004; Sheen and Macklis, 1995) which gives some grounds for optimism when considering HESC transplantation into the retina.
7.6. Inflammation and immune responses 7.6.1. Inflammation
Microglia are usually inactive (resting) in the normal retina but as a result of injury or disease they become activated very rapidly and migrate from the surrounding tissue to the site of damage (Roque et al., 1996; Thanos, 1992) . The inflammatory response is primarily co-ordinated by microglia/macrophages (Giulian, 1987; Langmann, 2007) and they form a barrier around the lesion, separating damaged tissue from undamaged (Davalos et al., 2005; Nimmerjahn et al., 2005) . Activated microglia produce IL-1b, IL-6, tumour necrosis factor-a (TNF a), nitric oxide and reactive oxygen species (reviewed by Langmann, 2007) which are detrimental to cell survival and, crucially for stem cell studies, IL-6 and TNFa have been identified as potent suppressors of neurogensis in vitro (Monje et al., 2003) . The strong microglial/inflammatory response induced by ischaemia or injection of lipopolysaccharide can also adversely affect neurogenesis. Pharmacological intervention using anti-inflammatory drugs such as indomethacin or minocycline can reverse the process (Ekdahl et al., 2003; Hoehn et al., 2005; Monje et al., 2003) . Inflammatory cytokines (produced by microglia and astrocytes) have been implicated in signalling migratory pathways for progenitor cells (see Section 7.6) but cell death has been also observed in these cells migrating along inflammatory cytokine pathways (Belmadani et al., 2006) . Bearing in mind that donor cells will be transplanted into degenerating or diseased retinae, their introduction into a microglial rich environment such as is seen in rd mice (Zeng et al., 2005) may compromise their survival. It may be that where damage is localised cytokine pathways may indeed guide cell migration, but where the tissue damage is widespread (as in some retinal diseases) the level of toxic cytokines produced may be detrimental to donor cell survival. Importantly, microglia can act as antigen-presenting cells and if donor cells are allografts or xenografts they could be destroyed by an immune-mediated response (see Section 7.6.2).
Macrophages may also be recruited from the bloodstream if the blood-retinal barrier has been breached (Kreutzberg, 1996) . Their role is to remove cell debris, but they too produce free radicals, nitric oxide and other toxic molecules.
An important complicating factor is that these inflammatory cells are autofluorescent, therefore double-labelling with markers for these cells as well as donor cells becomes a necessity to confirm true donor cell integration and maturation.
Immune rejection
This topic, although clearly important for transplantation studies, will only be briefly referred to in this review (instead see, for example, articles by Klassen et al. (2003 Klassen et al. ( , 2004a . The eye and brain have been considered to be immune-privileged sites partly because of the existence of the blood-retinal, blood-brain barrier. However, these barriers are often compromised in injured or diseased retinae and blood vessels become 'leaky' (Arend et al., 2005; Grisanti et al., 1997; Hernandez, 2000) . Any transplanted donor cell would then be exposed to immune surveillance by the circulating host lymphocytes (Wekerle et al., 1987) . Gene array data suggests that immunological maturity is a late event in gestation and embryonic stem cells do not reach this point (Drukker et al., 2006) . However, ESCs can express low levels of major histocompatibility protein I (MHCI) which can be upregulated, particularly by c-interferon (Drukker, 2004; Drukker et al., 2002) , which could occur after transplantation. The expression of MHCI may be sufficient to induce chronic rejection (Jiang et al., 2004) . Since foreign antigens must be presented to host T cells in association with MHCII (VanBuskirk et al., 1997) and since stem cells fail to express MHCII, they may have a lower potential for activating the immune system (Modo et al., 2002) , particularly if grafted into immune-privileged sites (Drukker, 2004) . However, recent papers have observed rejection of xenografted HESCs (Grinnemo et al., 2006) and cardiac committed mouse ESCs (Bonnevie et al., 2007) . In addition, it has become clear that the culture conditions for HESCs can confer unwanted immunogenicity (Martin et al., 2005) .
Even if HESCs initially escape immune detection, the question remains as to whether they will eventually express MHCs as they fully differentiate and mature. In fact it is preferable that ESCs should be fully differentiated prior to transplantation to ensure they do not harbour potential antigen-presenting cells. It may be that their presence in an immune-privileged site will remain undetected unless the blood-retinal barrier is breached at a later date either by injury or disease . Although embryonic stem cells may only express MHCI, it is likely that immunosuppression will have to be used, at least until the blood-retinal barrier has re-formed after surgery. Combination immunosuppressive therapy (tacrolimus and rapamycin) or CD4 antibodies have been found to be the most effective in prolonging the survival of xenografted human neural stem cells in a mouse model of amyotrophic lateral sclerosis (Yan et al., 2006) but they can influence how donor cells mature (Barker and Widner, 2004) . Alternative approaches may include the derivation of autologous progenitor cells (Muraoka et al., 2006) or the induction of immune tolerance (Jiang et al., 2004 (Jiang et al., , 2006 to HESC lines.
Finally, in future photoreceptor transplantation experiments (foetal, adult or HESC-derived cells) it is important to consider the potential host response to molecular ele-ments within grafted cells. Recoverin, a molecule characteristic of mature and developing photoreceptors has been implicated as having a causative role in cancer-associated retinopathy (Polans et al., 1993 (Polans et al., , 1995 Thirkill et al., 1992) . This condition is a type of para-neoplastic neuropathy during which cancerous tumours exert a remote effect on cellular components of the nervous system by initiating autoimmune responses. It has been demonstrated that injections of recoverin into rats prove effective in inducing degeneration of host photoreceptors (Adamus et al., 1994; Gery et al., 1994) . At present, many transplanted photoreceptor progenitors die following allografts from the same species . This raises the possibility that recoverin may be directly exposed to the host immune system following transplantation. As such, future studies should consider the possible long term impact of autoimmune responses on grafted and residual host photoreceptor populations.
Conclusions
In this review, we have presented data from the developmental literature in an effort to inform ongoing research into the derivation of therapeutically useful ocular cell types (RPE cells and photoreceptors). We highlight key signalling pathways (FGF and BMP/TGFb) from this literature and suggest that it is the balance between such molecules that may help HESCs differentiate towards specific retinal lineages.
In a sense, the plasticity of HESCs and their adaptability to in vitro life may help us to bias culture conditions towards the generation of ocular specific cell types. This is likely to involve either modifications to standard culture practices, or the application of correct combinations of growth factors and ECM cues during specified temporal windows. We suggest that serendipitously, existing derivation and propagation conditions (utilising feeders of mesenchymal origin) may already promote the differentiation of RPE cells from standard HESC cultures. However, as demonstrated recently by Lamba and colleagues (2006) , the key to obtaining maximal retinal lineage commitment from HESCs involves identifying the correct combinations of molecular cues to optimise efficiency of target cell derivation.
As different groups are now reaching the stage when functional in vivo studies can proceed prior to clinical application of HESC-derived retinal cell types, we have outlined issues surrounding the field of neural transplantation. It is hoped that a greater awareness of the complexities of the degenerating retinal environment and immunological issues surrounding the use of ES cells in cellular therapy will serve to enhance future pre-clinical animal studies. 
